Maine Revised Statutes
Subchapter 9: MISCELLANEOUS PROVISIONS
32 §13786-D. Prescribing and dispensing insulin

§13786-D. Prescribing and dispensing insulin
1.  Definitions.  As used in this section, unless the context otherwise indicates, the following terms have the following meanings.  
A. "Insulin" includes various types of insulin analogs and insulin-like medications, regardless of activation period or whether the solution is mixed before or after dispensation.   [PL 2019, c. 666, Pt. B, §1 (NEW).]
B. "Insulin-related devices and supplies" means needles, syringes, cartridge systems, prefilled pen systems, glucose meters and test strips. "Insulin-related devices and supplies" does not include insulin pump devices.   [PL 2019, c. 666, Pt. B, §1 (NEW).]
[PL 2019, c. 666, Pt. B, §1 (NEW).]
2.  Authorization.  As authorized by the board in accordance with rules adopted under subsection 3, a pharmacist may dispense emergency refills of insulin and associated insulin-related devices and supplies by prescription drug order or standing order or pursuant to a collaborative practice agreement authorizing insulin to be dispensed. The insulin dispensed under this subsection must be in a quantity that is at least a 30-day supply unless the intended recipient requests a lesser quantity upon consultation with the pharmacist. The intended recipient shall provide evidence of a previous prescription from a practitioner and attest that a refill of that previous prescription may not be readily or easily obtained under the circumstances. Upon receiving evidence of a previous prescription from a practitioner, the pharmacist shall immediately notify that practitioner that an emergency refill of insulin was dispensed and instruct the recipient to seek follow-up care from the practitioner as soon as possible.  
[PL 2021, c. 20, §1 (AMD).]
3.  Rules; protocols.  The board by rule shall establish standards for authorizing pharmacists to dispense insulin in accordance with subsection 2, including protocols for notifying practitioners when emergency refills of insulin are dispensed. Rules adopted under this subsection are routine technical rules as defined in Title 5, chapter 375, subchapter 2‑A.  
[PL 2021, c. 20, §2 (AMD).]
SECTION HISTORY
PL 2019, c. 666, Pt. B, §1 (NEW). PL 2021, c. 20, §§1, 2 (AMD).

Structure Maine Revised Statutes

Maine Revised Statutes

TITLE 32: PROFESSIONS AND OCCUPATIONS

Chapter 117: MAINE PHARMACY ACT

Subchapter 9: MISCELLANEOUS PROVISIONS

32 §13781. Generic and therapeutically equivalent substitution

32 §13782. Advertising

32 §13782-A. Price disclosure

32 §13783. Posting prices (REPEALED)

32 §13784. Patient information regulation

32 §13785. Patient profile record system regulation

32 §13786. Identification of persons prescribing medicines on hospital prescription blanks

32 §13786-A. Security requirements; rules

32 §13786-B. Partial dispensing of prescription for opioid medication

32 §13786-C. Dispensing of prescription of opioid medication; immunity

32 §13786-D. Prescribing and dispensing insulin

32 §13786-E. Prescribing, dispensing and administering HIV prevention drugs

32 §13786-F. Dispensing of emergency supplies of chronic maintenance drug

32 §13787. Hypodermic syringes; prescriptions (REPEALED)

32 §13787-A. Sale of hypodermic apparatus

32 §13788. Sale of poisonous drugs

32 §13789. Possession of drug samples

32 §13790. Using drugs not in prescription

32 §13791. Return of drugs

32 §13792. Sale by certain methods prohibited

32 §13793. Adulterating and selling drugs

32 §13794. Labeling of prescriptions

32 §13795. Photographic proof of identification; discretion to sell or dispense; immunity

32 §13796. Retail sale of targeted methamphetamine precursors

32 §13797. Prescription drug price information

32 §13798. Expedited partner therapy

32 §13799. Consumer choice preserved

32 §13800. Access to distributed drugs

32 §13800-A. Liability for product of another; exemption

32 §13800-B. Prohibition on providing conversion therapy to minors

32 §13800-C. Opioid medication product registration fee

32 §13800-D. Insulin product registration fee (WHOLE SECTION TEXT EFFECTIVE UNTIL 1/01/27) (WHOLE SECTION TEXT REPEALED 1/01/27)